Market Synopsis
Market
Research Future (MRFR) postulates that the global transfer membrane
market share is projected to reach USD 0.17 billion by 2030 at a healthy
CAGR of 2.1% during the forecast period (2023-2030). Transfer membrane is
referred to as the collection of mechanisms which control the passage of small
molecules and ions with the help of biological membranes. The surging funding
by the public and private organizations in terms of life science research is
highly favoring the market growth globally.
Global Transfer Membrane Market: Segmental Analysis
The global transfer membrane market outlook has been segmented on the basis of transfer method, type, application, and end user.
By mode of type, the global transfer membrane market has been segmented into PVDF transfer membranes, nitrocellulose transfer membranes, and nylon transfer membranes. Among these, the PVDF transfer membrane is considered to occupy the largest market share owing to its advantages over nitrocellulose membranes like hydrophobicity and higher durability, rising proteomic research, and growing R&D activities by the biotechnology and pharmaceutical companies.
By mode of transfer method, the global transfer membrane market has been segmented into dry electrotransfer, semi-dry electrotransfer, tank electrotransfer, and others. Among these, the tank electrotransfer is predicted to hold the largest share in the market.
By mode of application, the global transfer membrane market has been segmented into southern blotting, western blotting, protein sequencing & amino acid analysis, northern blotting, and others. Among these, the western blotting segment is anticipated to occupy the largest market share.
By mode of end-users, the global transfer membrane market has been segmented into diagnostic laboratories, pharmaceutical & biotechnology companies, academic and research institutes, and others. Among these, the pharmaceutical and biotechnology companies are estimated to occupy the largest share in the market.
Competitive Dashboard
The
global transfer membrane market players are Pall Corporation (Subsidiary of
Danaher Corporation), Santa Cruz Biotechnology, Merck KGaA, GVS, Bio-Rad
Laboratories, Azure Biosystems, PerkinElmer, Axiva Sichem Biotech, Advansta,
Carl Roth, Atto Corporation, Macherey-Nagel, GE Healthcare, Thermo Fisher
Scientific, Abcam, and others.
Market Potential and Pitfalls
Transfer
membrane market is rapidly stealing the limelight during the forecast period
owing to major factors such as augmenting R&D spending by the
biotechnological and pharmaceutical companies, augmenting demand for
polyvinylidene difluoride membrane, and increasing funding in order to support
the clinical researchers. For instance, according to the Office for National
Statistics, the gross domestic expenditure on R&D was Euro 33.1 billion in
2016 in the U.K.
The
transfer membrane market is expanding at breakneck speed due to the raising
funds for life sciences to target chronic diseases across the world. Scientific
developments in terms of implementation and introduction of the latest
treatment methods are further estimated to contribute to the global market
throughout the assessment period. Moreover, the increased funds in R&D of
pharmaceutical as well as biotechnological companies are triggering the demand
for transfer membrane across the globe.
On
the contrary, the dearth of skilled professionals in the healthcare sector and
the high availability of alternative methods are some of the top barriers
considered to vitiate the market growth throughout the appraisal period.
Despite such hiccups, the rising demand for a better remedy in terms of
pharmaceutical and biological advancements and a growing number of target
diseases are likely to influence the market growth in the long run.
Regional Insights
Geographically,
the transfer membrane market insights span across regions namely, Europe,
America, Asia-Pacific, and the Middle East & Africa.
Considering
the global scenario, the transfer membrane market is dominated by the American
region due to the presence of well-established players. With technological
advancements in the healthcare sector, surging funding by the government in
order to support R&D, and growing demand for transfer methods in this
region the market is region is estimated to propel.
The
European region is estimated to occupy the second position in the global market
and is likely to retain its growth in the long run. The growth is credited to
the raising funds in order to support the preclinical researchers.
The
Asia Pacific region is estimated to experience the fastest growth rate owing to
the expanding proteomics research, the growing prevalence of target diseases in
several economies in this region, and a rising scale of life sciences projects
funded by the private and government bodies.
About US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
